Global and China Alzheimer's Drugs Research Report 2024-2032 Featuring Industry Leaders - Abbvie, AstraZeneca, Biogen, Eisai, Eli Lilly, Lundbeck, Roche, Merck, Novartis, Ono, Pfizer, and Teva
June 25, 2024 07:20 ET
|
Research and Markets
Dublin, June 25, 2024 (GLOBE NEWSWIRE) -- The "Alzheimer's Drugs Market Report by Drug Class, Drug Type, Distribution Channel, Region and Company Analysis 2024-2032" report has been added to ...
Alzheimer's Disease Pipeline Landscape 2024: Comprehensive Insights About 110+ Companies and 120+ Drugs
June 17, 2024 07:01 ET
|
Research and Markets
Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Alzheimer's Disease - Pipeline Insights, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Japan Alzheimer's Disease Market Forecast to 2032 Demonstrates Increasing Diagnosed Prevalence and Growth Following Novel Treatment Approaches
January 25, 2024 09:02 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Japan Alzheimer's Disease - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The...
Global Alzheimer's Disease Industry Forecast, 2032: Breakthrough Therapies and Market Trends
August 23, 2023 05:53 ET
|
Research and Markets
Dublin, Aug. 23, 2023 (GLOBE NEWSWIRE) -- The "Global Alzheimer's Disease Market 2023-2032" report has been added to ResearchAndMarkets.com's offering. Alzheimer's disease, a progressive...
World Alzheimer's Disease Therapeutics Analysis Report 2022: A $4.26 Billion Market by 2028 - Market Insights, Epidemiology and Pipeline Assessments
February 15, 2023 06:58 ET
|
Research and Markets
Dublin, Feb. 15, 2023 (GLOBE NEWSWIRE) -- The "Alzheimer's Disease Therapeutics (2022 Edition) - Market Insight, Epidemiology and Pipeline Assessment (By Molecule Type, By Route of Administration,...
Global Alzheimer's Disease Therapeutics Market Research Report 2023: Forecasts, Epidemiology & Pipeline Analysis 2022-2028
February 08, 2023 10:23 ET
|
Research and Markets
Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Alzheimer's Disease Therapeutics Market Forecast - Epidemiology & Pipeline Analysis 2023-2028" report has been added to ResearchAndMarkets.com's...
Global Alzheimer's Drugs Market Report 2023 - 2027: Key Players Include Sanofi, F. Hoffmann-La Roche, Pfizer and Abbott Laboratories
January 24, 2023 09:13 ET
|
Research and Markets
Dublin, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The "Alzheimer's Drugs Market, Global Forecast 2023-2027, Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ...
Alzheimers Therapeutic Global Market Report 2022: High Estimates of Future Cases Driving Development & Innovation
October 11, 2022 05:18 ET
|
Research and Markets
Dublin, Oct. 11, 2022 (GLOBE NEWSWIRE) -- The "Alzheimers Therapeutic Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
US Alzheimer's Disease Drug Market Clinical Trials Insight 2026 - Clinical Insight on 200 Alzheimer's Disease Drug in Pipeline
February 22, 2021 04:28 ET
|
Research and Markets
Dublin, Feb. 22, 2021 (GLOBE NEWSWIRE) -- The "US Alzheimer's Disease Drug Market, Dosage, Price & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. US...
Global Alzheimer's Disease Diagnostics and Therapeutics Market to 2025: Use of Biomarkers in Diagnosis and Drug Development & Large Number of Drugs in Pipeline
January 14, 2021 09:33 ET
|
Research and Markets
Dublin, Jan. 14, 2021 (GLOBE NEWSWIRE) -- The "Alzheimer's Disease Diagnostics and Therapeutics Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to...